New treatments of hyperandrogenism and hirsutism

Obstetrics and Gynecology Clinics of North America

Volumn 27, Issue 3, 2000, Pages 567-581

  Hock, Doreen L ^b   Seifer, David B ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; BROMOCRIPTINE; ORAL CONTRACEPTIVE AGENT;

ANDROGEN RELEASE; HAIR GROWTH; HIRSUTISM; HUMAN; HYPERANDROGENISM; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL;

EID: 0033840783     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70156-X     Document Type: Article

References (60)

1. Can metformin reduce insulin resistance in polycystic ovary syndrome?
2. Pathophysiology and evaluation of adrenal hyperandrogenism
3. Deletion of steroid 5a reductase 2 gene in male pseudohermaphroditism
4. Hyperandrogenic disorders
5. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin
6. Physiologic estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonists in the treatment of hirsutism
7. Chiroinositol deficiency and insulin resistance
8. Treatment of hirsutism with the pure antiandrogen flutamide
9. Hair
10. The action of hormones on spontaneous hair growth cycles in the rat
11. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome
12. Combination gonadotropin releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism
13. Clinical assessment of body hair growth in women
14. Specificity spillover at the hormone receptor: Exploring its role in human disease
15. Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome
16. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope
17. Endocrine changes after laparoscopic ovarian cautery in polycystic ovarian syndrome
18. Age, sex and genetic factors in the regulation of hair growth in man: A comparison of Caucasian and Japanese populations
19. The structure of human hair
20. Efficacy and metabolic effects of metformin and troglitazone in type 2 diabetes mellitus
21. Circulating luteinizing hormone pulse frequency in women with polycystic ovary syndrome
22. Clinical and laboratory evaluation of hirsutism
23. Metformin improves hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome
24. Late onset adrenal hyperplasia in hirsutism
25. Multiple pathways in insulin signaling - Fitting the covalent and allosteric puzzle pieces together
26. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease
27. Effect of pregnancy on the human hair cycle
28. Shaving and hair growth
29. Treatment of hirsutism with flutamide
30. Regulation of androgen receptor and 5γ reductase in the skin of normal and hirsute women
31. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors
32. Androgen metabolism in hirsute patients treated with cyproterone acetate
33. Effect of low dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women
34. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
35. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17α activity and serum androgens
36. Ovulatory and metabolic effects of D-chiroinositol in the polycystic ovary syndrome
37. Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated with insulin resistance in spontaneously diabetic rhesus monkeys
38. Embryology of hair
39. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome
40. Testosterone metabolism in the skin
41. Treatment of androgenetic disorders in women: Acne, hirsutism, and alopecia
42. Temporary hair removal in patients with hirsutism: A clinical study
43. Clinical review 73: Medical treatment of androgen dependent hirsutism
44. Evaluation and treatment of hirsutism
45. Human hair cycle
46. Treatment of hirsutism
47. The hair cycle on the human thigh and upper arm
48. The effects of spironolactone on adrenal steroidogenesis in hirsute women
49. A novel use of spironolactone: Treatment of hirsutism
50. Diagnosis and management of polycystic ovary syndrome
51. Hirsutism
52. Preoperative localization of androgen secreting tumors: Clinical, endocrinologic, and radiologic evaluation of ten patients
53. Urinary chiroinositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes
54. The regional frequency and distribution of hair follicles in human skin
55. Treatment of hirsutism with spironolactone
56. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
57. Ketoconazole therapy for women with acne and/or hirsutism
58. Characterization of the cytosol androgen receptor of the human prostate
59. Physical methods for the management of hirsutism
60. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women